 | • レポートコード：QFJ1-4156 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、128ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、癌におけるドラッグデリバリーの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（リポソーム、PEG化タンパク質＆ポリペプチド、ポリマーナノ粒子、タンパク質薬物複合体、その他）、用途別市場規模（病院＆診療所、がん治療センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・癌におけるドラッグデリバリーの市場動向 ・企業の競争状況、市場シェア ・癌におけるドラッグデリバリーの種類別市場規模と予測2016-2027（リポソーム、PEG化タンパク質＆ポリペプチド、ポリマーナノ粒子、タンパク質薬物複合体、その他） ・癌におけるドラッグデリバリーの用途別市場規模と予測2016-2027（病院＆診療所、がん治療センター、その他） ・癌におけるドラッグデリバリーの北米市場規模2016-2027（アメリカ、カナダ） ・癌におけるドラッグデリバリーの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・癌におけるドラッグデリバリーのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・癌におけるドラッグデリバリーの中南米市場規模2016-2027（メキシコ、ブラジル） ・癌におけるドラッグデリバリーの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Amgen、Teva、UCB (Union Chimique Belge)、Roche、Celgene、Sanofi、Merck、Johnson & Johnson、Takeda、Gilead Sciences、Pfizer、Dr Reddy、Samyang Biopharmaceuticals、Tolmar、Astellas、AMAG Pharmaceuticals、AstraZeneca、AbbVie、Novartis、Aspen、Shire (Baxalta)、Breckenridge Pharmaceuticals、Galen Pharmaceuticals） ・結論 |
Market Analysis and Insights: Global Drug Delivery in Cancer Market
The global Drug Delivery in Cancer market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Drug Delivery in Cancer market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Drug Delivery in Cancer market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Drug Delivery in Cancer market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Drug Delivery in Cancer market.
Global Drug Delivery in Cancer Scope and Market Size
Drug Delivery in Cancer market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Drug Delivery in Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Liposomes
PEGylated Proteins & Polypeptides
Polymer Nanoparticle
Protein–drug Conjugates
Others
Segment by Application
Hospitals & Clinic
Cancer Treatment Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Amgen
Teva
UCB (Union Chimique Belge)
Roche
Celgene
Sanofi
Merck
Johnson & Johnson
Takeda
Gilead Sciences
Pfizer
Dr Reddy
Samyang Biopharmaceuticals
Tolmar
Astellas
AMAG Pharmaceuticals
AstraZeneca
AbbVie
Novartis
Aspen
Shire (Baxalta)
Breckenridge Pharmaceuticals
Galen Pharmaceuticals
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Delivery in Cancer Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Liposomes
1.2.3 PEGylated Proteins & Polypeptides
1.2.4 Polymer Nanoparticle
1.2.5 Protein–drug Conjugates
1.2.6 Others
1.3 Market by Application
1.3.1 Global Drug Delivery in Cancer Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals & Clinic
1.3.3 Cancer Treatment Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Drug Delivery in Cancer Market Perspective (2016-2027)
2.2 Drug Delivery in Cancer Growth Trends by Regions
2.2.1 Drug Delivery in Cancer Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Drug Delivery in Cancer Historic Market Share by Regions (2016-2021)
2.2.3 Drug Delivery in Cancer Forecasted Market Size by Regions (2022-2027)
2.3 Drug Delivery in Cancer Industry Dynamic
2.3.1 Drug Delivery in Cancer Market Trends
2.3.2 Drug Delivery in Cancer Market Drivers
2.3.3 Drug Delivery in Cancer Market Challenges
2.3.4 Drug Delivery in Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Delivery in Cancer Players by Revenue
3.1.1 Global Top Drug Delivery in Cancer Players by Revenue (2016-2021)
3.1.2 Global Drug Delivery in Cancer Revenue Market Share by Players (2016-2021)
3.2 Global Drug Delivery in Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Drug Delivery in Cancer Revenue
3.4 Global Drug Delivery in Cancer Market Concentration Ratio
3.4.1 Global Drug Delivery in Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Delivery in Cancer Revenue in 2020
3.5 Drug Delivery in Cancer Key Players Head office and Area Served
3.6 Key Players Drug Delivery in Cancer Product Solution and Service
3.7 Date of Enter into Drug Delivery in Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Delivery in Cancer Breakdown Data by Type
4.1 Global Drug Delivery in Cancer Historic Market Size by Type (2016-2021)
4.2 Global Drug Delivery in Cancer Forecasted Market Size by Type (2022-2027)
5 Drug Delivery in Cancer Breakdown Data by Application
5.1 Global Drug Delivery in Cancer Historic Market Size by Application (2016-2021)
5.2 Global Drug Delivery in Cancer Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Drug Delivery in Cancer Market Size (2016-2027)
6.2 North America Drug Delivery in Cancer Market Size by Type
6.2.1 North America Drug Delivery in Cancer Market Size by Type (2016-2021)
6.2.2 North America Drug Delivery in Cancer Market Size by Type (2022-2027)
6.2.3 North America Drug Delivery in Cancer Market Size by Type (2016-2027)
6.3 North America Drug Delivery in Cancer Market Size by Application
6.3.1 North America Drug Delivery in Cancer Market Size by Application (2016-2021)
6.3.2 North America Drug Delivery in Cancer Market Size by Application (2022-2027)
6.3.3 North America Drug Delivery in Cancer Market Size by Application (2016-2027)
6.4 North America Drug Delivery in Cancer Market Size by Country
6.4.1 North America Drug Delivery in Cancer Market Size by Country (2016-2021)
6.4.2 North America Drug Delivery in Cancer Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Drug Delivery in Cancer Market Size (2016-2027)
7.2 Europe Drug Delivery in Cancer Market Size by Type
7.2.1 Europe Drug Delivery in Cancer Market Size by Type (2016-2021)
7.2.2 Europe Drug Delivery in Cancer Market Size by Type (2022-2027)
7.2.3 Europe Drug Delivery in Cancer Market Size by Type (2016-2027)
7.3 Europe Drug Delivery in Cancer Market Size by Application
7.3.1 Europe Drug Delivery in Cancer Market Size by Application (2016-2021)
7.3.2 Europe Drug Delivery in Cancer Market Size by Application (2022-2027)
7.3.3 Europe Drug Delivery in Cancer Market Size by Application (2016-2027)
7.4 Europe Drug Delivery in Cancer Market Size by Country
7.4.1 Europe Drug Delivery in Cancer Market Size by Country (2016-2021)
7.4.2 Europe Drug Delivery in Cancer Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Drug Delivery in Cancer Market Size (2016-2027)
8.2 Asia-Pacific Drug Delivery in Cancer Market Size by Type
8.2.1 Asia-Pacific Drug Delivery in Cancer Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Drug Delivery in Cancer Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Drug Delivery in Cancer Market Size by Type (2016-2027)
8.3 Asia-Pacific Drug Delivery in Cancer Market Size by Application
8.3.1 Asia-Pacific Drug Delivery in Cancer Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Drug Delivery in Cancer Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Drug Delivery in Cancer Market Size by Application (2016-2027)
8.4 Asia-Pacific Drug Delivery in Cancer Market Size by Region
8.4.1 Asia-Pacific Drug Delivery in Cancer Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Drug Delivery in Cancer Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Drug Delivery in Cancer Market Size (2016-2027)
9.2 Latin America Drug Delivery in Cancer Market Size by Type
9.2.1 Latin America Drug Delivery in Cancer Market Size by Type (2016-2021)
9.2.2 Latin America Drug Delivery in Cancer Market Size by Type (2022-2027)
9.2.3 Latin America Drug Delivery in Cancer Market Size by Type (2016-2027)
9.3 Latin America Drug Delivery in Cancer Market Size by Application
9.3.1 Latin America Drug Delivery in Cancer Market Size by Application (2016-2021)
9.3.2 Latin America Drug Delivery in Cancer Market Size by Application (2022-2027)
9.3.3 Latin America Drug Delivery in Cancer Market Size by Application (2016-2027)
9.4 Latin America Drug Delivery in Cancer Market Size by Country
9.4.1 Latin America Drug Delivery in Cancer Market Size by Country (2016-2021)
9.4.2 Latin America Drug Delivery in Cancer Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Delivery in Cancer Market Size (2016-2027)
10.2 Middle East & Africa Drug Delivery in Cancer Market Size by Type
10.2.1 Middle East & Africa Drug Delivery in Cancer Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Drug Delivery in Cancer Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Drug Delivery in Cancer Market Size by Type (2016-2027)
10.3 Middle East & Africa Drug Delivery in Cancer Market Size by Application
10.3.1 Middle East & Africa Drug Delivery in Cancer Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Drug Delivery in Cancer Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Drug Delivery in Cancer Market Size by Application (2016-2027)
10.4 Middle East & Africa Drug Delivery in Cancer Market Size by Country
10.4.1 Middle East & Africa Drug Delivery in Cancer Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Drug Delivery in Cancer Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Drug Delivery in Cancer Introduction
11.1.4 Amgen Revenue in Drug Delivery in Cancer Business (2016-2021)
11.1.5 Amgen Recent Development
11.2 Teva
11.2.1 Teva Company Details
11.2.2 Teva Business Overview
11.2.3 Teva Drug Delivery in Cancer Introduction
11.2.4 Teva Revenue in Drug Delivery in Cancer Business (2016-2021)
11.2.5 Teva Recent Development
11.3 UCB (Union Chimique Belge)
11.3.1 UCB (Union Chimique Belge) Company Details
11.3.2 UCB (Union Chimique Belge) Business Overview
11.3.3 UCB (Union Chimique Belge) Drug Delivery in Cancer Introduction
11.3.4 UCB (Union Chimique Belge) Revenue in Drug Delivery in Cancer Business (2016-2021)
11.3.5 UCB (Union Chimique Belge) Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Drug Delivery in Cancer Introduction
11.4.4 Roche Revenue in Drug Delivery in Cancer Business (2016-2021)
11.4.5 Roche Recent Development
11.5 Celgene
11.5.1 Celgene Company Details
11.5.2 Celgene Business Overview
11.5.3 Celgene Drug Delivery in Cancer Introduction
11.5.4 Celgene Revenue in Drug Delivery in Cancer Business (2016-2021)
11.5.5 Celgene Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Drug Delivery in Cancer Introduction
11.6.4 Sanofi Revenue in Drug Delivery in Cancer Business (2016-2021)
11.6.5 Sanofi Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Drug Delivery in Cancer Introduction
11.7.4 Merck Revenue in Drug Delivery in Cancer Business (2016-2021)
11.7.5 Merck Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Details
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Drug Delivery in Cancer Introduction
11.8.4 Johnson & Johnson Revenue in Drug Delivery in Cancer Business (2016-2021)
11.8.5 Johnson & Johnson Recent Development
11.9 Takeda
11.9.1 Takeda Company Details
11.9.2 Takeda Business Overview
11.9.3 Takeda Drug Delivery in Cancer Introduction
11.9.4 Takeda Revenue in Drug Delivery in Cancer Business (2016-2021)
11.9.5 Takeda Recent Development
11.10 Gilead Sciences
11.10.1 Gilead Sciences Company Details
11.10.2 Gilead Sciences Business Overview
11.10.3 Gilead Sciences Drug Delivery in Cancer Introduction
11.10.4 Gilead Sciences Revenue in Drug Delivery in Cancer Business (2016-2021)
11.10.5 Gilead Sciences Recent Development
11.11 Pfizer
11.11.1 Pfizer Company Details
11.11.2 Pfizer Business Overview
11.11.3 Pfizer Drug Delivery in Cancer Introduction
11.11.4 Pfizer Revenue in Drug Delivery in Cancer Business (2016-2021)
11.11.5 Pfizer Recent Development
11.12 Dr Reddy
11.12.1 Dr Reddy Company Details
11.12.2 Dr Reddy Business Overview
11.12.3 Dr Reddy Drug Delivery in Cancer Introduction
11.12.4 Dr Reddy Revenue in Drug Delivery in Cancer Business (2016-2021)
11.12.5 Dr Reddy Recent Development
11.13 Samyang Biopharmaceuticals
11.13.1 Samyang Biopharmaceuticals Company Details
11.13.2 Samyang Biopharmaceuticals Business Overview
11.13.3 Samyang Biopharmaceuticals Drug Delivery in Cancer Introduction
11.13.4 Samyang Biopharmaceuticals Revenue in Drug Delivery in Cancer Business (2016-2021)
11.13.5 Samyang Biopharmaceuticals Recent Development
11.14 Tolmar
11.14.1 Tolmar Company Details
11.14.2 Tolmar Business Overview
11.14.3 Tolmar Drug Delivery in Cancer Introduction
11.14.4 Tolmar Revenue in Drug Delivery in Cancer Business (2016-2021)
11.14.5 Tolmar Recent Development
11.15 Astellas
11.15.1 Astellas Company Details
11.15.2 Astellas Business Overview
11.15.3 Astellas Drug Delivery in Cancer Introduction
11.15.4 Astellas Revenue in Drug Delivery in Cancer Business (2016-2021)
11.15.5 Astellas Recent Development
11.16 AMAG Pharmaceuticals
11.16.1 AMAG Pharmaceuticals Company Details
11.16.2 AMAG Pharmaceuticals Business Overview
11.16.3 AMAG Pharmaceuticals Drug Delivery in Cancer Introduction
11.16.4 AMAG Pharmaceuticals Revenue in Drug Delivery in Cancer Business (2016-2021)
11.16.5 AMAG Pharmaceuticals Recent Development
11.17 AstraZeneca
11.17.1 AstraZeneca Company Details
11.17.2 AstraZeneca Business Overview
11.17.3 AstraZeneca Drug Delivery in Cancer Introduction
11.17.4 AstraZeneca Revenue in Drug Delivery in Cancer Business (2016-2021)
11.17.5 AstraZeneca Recent Development
11.18 AbbVie
11.18.1 AbbVie Company Details
11.18.2 AbbVie Business Overview
11.18.3 AbbVie Drug Delivery in Cancer Introduction
11.18.4 AbbVie Revenue in Drug Delivery in Cancer Business (2016-2021)
11.18.5 AbbVie Recent Development
11.18 Novartis
.1 Novartis Company Details
.2 Novartis Business Overview
.3 Novartis Drug Delivery in Cancer Introduction
.4 Novartis Revenue in Drug Delivery in Cancer Business (2016-2021)
.5 Novartis Recent Development
11.20 Aspen
11.20.1 Aspen Company Details
11.20.2 Aspen Business Overview
11.20.3 Aspen Drug Delivery in Cancer Introduction
11.20.4 Aspen Revenue in Drug Delivery in Cancer Business (2016-2021)
11.20.5 Aspen Recent Development
11.21 Shire (Baxalta)
11.21.1 Shire (Baxalta) Company Details
11.21.2 Shire (Baxalta) Business Overview
11.21.3 Shire (Baxalta) Drug Delivery in Cancer Introduction
11.21.4 Shire (Baxalta) Revenue in Drug Delivery in Cancer Business (2016-2021)
11.21.5 Shire (Baxalta) Recent Development
11.22 Breckenridge Pharmaceuticals
11.22.1 Breckenridge Pharmaceuticals Company Details
11.22.2 Breckenridge Pharmaceuticals Business Overview
11.22.3 Breckenridge Pharmaceuticals Drug Delivery in Cancer Introduction
11.22.4 Breckenridge Pharmaceuticals Revenue in Drug Delivery in Cancer Business (2016-2021)
11.22.5 Breckenridge Pharmaceuticals Recent Development
11.23 Galen Pharmaceuticals
11.23.1 Galen Pharmaceuticals Company Details
11.23.2 Galen Pharmaceuticals Business Overview
11.23.3 Galen Pharmaceuticals Drug Delivery in Cancer Introduction
11.23.4 Galen Pharmaceuticals Revenue in Drug Delivery in Cancer Business (2016-2021)
11.23.5 Galen Pharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Drug Delivery in Cancer Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Liposomes
Table 3. Key Players of PEGylated Proteins & Polypeptides
Table 4. Key Players of Polymer Nanoparticle
Table 5. Key Players of Protein–drug Conjugates
Table 6. Key Players of Others
Table 7. Global Drug Delivery in Cancer Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Drug Delivery in Cancer Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Drug Delivery in Cancer Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Drug Delivery in Cancer Market Share by Regions (2016-2021)
Table 11. Global Drug Delivery in Cancer Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Drug Delivery in Cancer Market Share by Regions (2022-2027)
Table 13. Drug Delivery in Cancer Market Trends
Table 14. Drug Delivery in Cancer Market Drivers
Table 15. Drug Delivery in Cancer Market Challenges
Table 16. Drug Delivery in Cancer Market Restraints
Table 17. Global Drug Delivery in Cancer Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Drug Delivery in Cancer Market Share by Players (2016-2021)
Table 19. Global Top Drug Delivery in Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Delivery in Cancer as of 2020)
Table 20. Ranking of Global Top Drug Delivery in Cancer Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Drug Delivery in Cancer Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Drug Delivery in Cancer Product Solution and Service
Table 24. Date of Enter into Drug Delivery in Cancer Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Drug Delivery in Cancer Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Drug Delivery in Cancer Revenue Market Share by Type (2016-2021)
Table 28. Global Drug Delivery in Cancer Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Drug Delivery in Cancer Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Drug Delivery in Cancer Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Drug Delivery in Cancer Revenue Market Share by Application (2016-2021)
Table 32. Global Drug Delivery in Cancer Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Drug Delivery in Cancer Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Drug Delivery in Cancer Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Drug Delivery in Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Drug Delivery in Cancer Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Drug Delivery in Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Drug Delivery in Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Drug Delivery in Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Drug Delivery in Cancer Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Drug Delivery in Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Drug Delivery in Cancer Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Drug Delivery in Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Drug Delivery in Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Drug Delivery in Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Drug Delivery in Cancer Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Drug Delivery in Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Drug Delivery in Cancer Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Drug Delivery in Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Drug Delivery in Cancer Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Drug Delivery in Cancer Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Drug Delivery in Cancer Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Drug Delivery in Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Drug Delivery in Cancer Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Drug Delivery in Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Drug Delivery in Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Drug Delivery in Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Drug Delivery in Cancer Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Drug Delivery in Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Drug Delivery in Cancer Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Drug Delivery in Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Drug Delivery in Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Drug Delivery in Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 64. Amgen Company Details
Table 65. Amgen Business Overview
Table 66. Amgen Drug Delivery in Cancer Product
Table 67. Amgen Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
Table 68. Amgen Recent Development
Table 69. Teva Company Details
Table 70. Teva Business Overview
Table 71. Teva Drug Delivery in Cancer Product
Table 72. Teva Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
Table 73. Teva Recent Development
Table 74. UCB (Union Chimique Belge) Company Details
Table 75. UCB (Union Chimique Belge) Business Overview
Table 76. UCB (Union Chimique Belge) Drug Delivery in Cancer Product
Table 77. UCB (Union Chimique Belge) Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
Table 78. UCB (Union Chimique Belge) Recent Development
Table 79. Roche Company Details
Table 80. Roche Business Overview
Table 81. Roche Drug Delivery in Cancer Product
Table 82. Roche Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
Table 83. Roche Recent Development
Table 84. Celgene Company Details
Table 85. Celgene Business Overview
Table 86. Celgene Drug Delivery in Cancer Product
Table 87. Celgene Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
Table 88. Celgene Recent Development
Table 89. Sanofi Company Details
Table 90. Sanofi Business Overview
Table 91. Sanofi Drug Delivery in Cancer Product
Table 92. Sanofi Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
Table 93. Sanofi Recent Development
Table 94. Merck Company Details
Table 95. Merck Business Overview
Table 96. Merck Drug Delivery in Cancer Product
Table 97. Merck Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
Table 98. Merck Recent Development
Table 99. Johnson & Johnson Company Details
Table 100. Johnson & Johnson Business Overview
Table 101. Johnson & Johnson Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
Table 102. Johnson & Johnson Recent Development
Table 103. Takeda Company Details
Table 104. Takeda Business Overview
Table 105. Takeda Drug Delivery in Cancer Product
Table 106. Takeda Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
Table 107. Takeda Recent Development
Table 108. Gilead Sciences Company Details
Table 109. Gilead Sciences Business Overview
Table 110. Gilead Sciences Drug Delivery in Cancer Product
Table 111. Gilead Sciences Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
Table 112. Gilead Sciences Recent Development
Table 113. Pfizer Company Details
Table 114. Pfizer Business Overview
Table 115. Pfizer Drug Delivery in Cancer Product
Table 116. Pfizer Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
Table 117. Pfizer Recent Development
Table 118. Dr Reddy Company Details
Table 119. Dr Reddy Business Overview
Table 120. Dr Reddy Drug Delivery in Cancer Product
Table 121. Dr Reddy Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
Table 122. Dr Reddy Recent Development
Table 123. Samyang Biopharmaceuticals Company Details
Table 124. Samyang Biopharmaceuticals Business Overview
Table 125. Samyang Biopharmaceuticals Drug Delivery in Cancer Product
Table 126. Samyang Biopharmaceuticals Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
Table 127. Samyang Biopharmaceuticals Recent Development
Table 128. Tolmar Company Details
Table 129. Tolmar Business Overview
Table 130. Tolmar Drug Delivery in Cancer Product
Table 131. Tolmar Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
Table 132. Tolmar Recent Development
Table 133. Astellas Company Details
Table 134. Astellas Business Overview
Table 135. Astellas Drug Delivery in Cancer Product
Table 136. Astellas Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
Table 137. Astellas Recent Development
Table 138. AMAG Pharmaceuticals Company Details
Table 139. AMAG Pharmaceuticals Business Overview
Table 140. AMAG Pharmaceuticals Drug Delivery in Cancer Product
Table 141. AMAG Pharmaceuticals Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
Table 142. AMAG Pharmaceuticals Recent Development
Table 143. AstraZeneca Company Details
Table 144. AstraZeneca Business Overview
Table 145. AstraZeneca Drug Delivery in Cancer Product
Table 146. AstraZeneca Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
Table 147. AstraZeneca Recent Development
Table 148. AbbVie Company Details
Table 149. AbbVie Business Overview
Table 150. AbbVie Drug Delivery in Cancer Product
Table 151. AbbVie Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
Table 152. AbbVie Recent Development
Table 153. Novartis Company Details
Table 154. Novartis Business Overview
Table 155. Novartis Drug Delivery in Cancer Product
Table 156. Novartis Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
Table 157. Novartis Recent Development
Table 158. Aspen Company Details
Table 159. Aspen Business Overview
Table 160. Aspen Drug Delivery in Cancer Product
Table 161. Aspen Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
Table 162. Aspen Recent Development
Table 163. Shire (Baxalta) Company Details
Table 164. Shire (Baxalta) Business Overview
Table 165. Shire (Baxalta) Drug Delivery in Cancer Product
Table 166. Shire (Baxalta) Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
Table 167. Shire (Baxalta) Recent Development
Table 168. Breckenridge Pharmaceuticals Company Details
Table 169. Breckenridge Pharmaceuticals Business Overview
Table 170. Breckenridge Pharmaceuticals Drug Delivery in Cancer Product
Table 171. Breckenridge Pharmaceuticals Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
Table 172. Breckenridge Pharmaceuticals Recent Development
Table 173. Galen Pharmaceuticals Company Details
Table 174. Galen Pharmaceuticals Business Overview
Table 175. Galen Pharmaceuticals Drug Delivery in Cancer Product
Table 176. Galen Pharmaceuticals Revenue in Drug Delivery in Cancer Business (2016-2021) & (US$ Million)
Table 177. Galen Pharmaceuticals Recent Development
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drug Delivery in Cancer Market Share by Type: 2020 VS 2027
Figure 2. Liposomes Features
Figure 3. PEGylated Proteins & Polypeptides Features
Figure 4. Polymer Nanoparticle Features
Figure 5. Protein–drug Conjugates Features
Figure 6. Others Features
Figure 7. Global Drug Delivery in Cancer Market Share by Application: 2020 VS 2027
Figure 8. Hospitals & Clinic Case Studies
Figure 9. Cancer Treatment Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Drug Delivery in Cancer Report Years Considered
Figure 12. Global Drug Delivery in Cancer Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Drug Delivery in Cancer Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Drug Delivery in Cancer Market Share by Regions: 2020 VS 2027
Figure 15. Global Drug Delivery in Cancer Market Share by Regions (2022-2027)
Figure 16. Global Drug Delivery in Cancer Market Share by Players in 2020
Figure 17. Global Top Drug Delivery in Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Delivery in Cancer as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Drug Delivery in Cancer Revenue in 2020
Figure 19. Global Drug Delivery in Cancer Revenue Market Share by Type (2016-2021)
Figure 20. Global Drug Delivery in Cancer Revenue Market Share by Type (2022-2027)
Figure 21. North America Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Drug Delivery in Cancer Market Share by Type (2016-2027)
Figure 23. North America Drug Delivery in Cancer Market Share by Application (2016-2027)
Figure 24. North America Drug Delivery in Cancer Market Share by Country (2016-2027)
Figure 25. United States Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Drug Delivery in Cancer Market Share by Type (2016-2027)
Figure 29. Europe Drug Delivery in Cancer Market Share by Application (2016-2027)
Figure 30. Europe Drug Delivery in Cancer Market Share by Country (2016-2027)
Figure 31. Germany Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Drug Delivery in Cancer Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Drug Delivery in Cancer Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Drug Delivery in Cancer Market Share by Region (2016-2027)
Figure 41. China Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Drug Delivery in Cancer Market Share by Type (2016-2027)
Figure 49. Latin America Drug Delivery in Cancer Market Share by Application (2016-2027)
Figure 50. Latin America Drug Delivery in Cancer Market Share by Country (2016-2027)
Figure 51. Mexico Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Drug Delivery in Cancer Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Drug Delivery in Cancer Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Drug Delivery in Cancer Market Share by Country (2016-2027)
Figure 57. Turkey Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Drug Delivery in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Amgen Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
Figure 61. Teva Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
Figure 62. UCB (Union Chimique Belge) Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
Figure 63. Roche Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
Figure 64. Celgene Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
Figure 65. Sanofi Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
Figure 66. Merck Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
Figure 67. Johnson & Johnson Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
Figure 68. Takeda Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
Figure 69. Gilead Sciences Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
Figure 70. Pfizer Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
Figure 71. Dr Reddy Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
Figure 72. Samyang Biopharmaceuticals Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
Figure 73. Tolmar Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
Figure 74. Astellas Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
Figure 75. AMAG Pharmaceuticals Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
Figure 76. AstraZeneca Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
Figure 77. AbbVie Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
Figure 78. Novartis Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
Figure 79. Aspen Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
Figure 80. Shire (Baxalta) Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
Figure 81. Breckenridge Pharmaceuticals Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
Figure 82. Galen Pharmaceuticals Revenue Growth Rate in Drug Delivery in Cancer Business (2016-2021)
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed
世界のがん生物毒素治療薬市場規模・現状・予測（2021年-2027年） Treatment of cancer disease depends on the stage of disease progression. Chemotherapy is widely used in earlier stages but there are other therapy options like immunological therapy and targeted drugs used in later stages. Market Analysis and Insights: Global Cancer Biological Toxins Drug Market The…- 世界のドラッグデリバリーアクロス血液脳関門市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Drug Delivery Across Blood Brain Barrier Market The global Drug Delivery Across Blood Brain Barrier market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analys…
- 世界の乳がん診断＆薬物技術市場規模・現状・予測（2021年-2027年） Breast cancer is a malignant tumor that occurs in the epithelial tissue of the breast gland.Breast Cancer Diagnostic and Drug Technologies include mammography, biopsy and so on. Market Analysis and Insights: Global Breast Cancer Diagnostic and Drug Technologies Market The global Breast Cancer Diagno…
- 世界の経粘膜薬物送達システム市場規模・現状・予測（2021年-2027年） The transmucosal route includes oral, nasal, vaginal, and urethral and presents a challenge in the field of novel drug delivery technology. The transmucosal membranes are relatively permeable, have a rich blood flow and hence allow the rapid uptake of a drug into systemic circulation to avoid first …
- ポリマー薬物コンジュゲートのグローバル市場調査 2019年 The global Polymer Drug Conjugates market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Polymer Drug Conjugates volume and value at global level, regional level and company level. From a global perspecti…